Status:

RECRUITING

Planning Operative Strategy Using a Digital Renal Artery Clamping Tool

Lead Sponsor:

University Hospital, Ghent

Collaborating Sponsors:

Stichting tegen Kanker

University Ghent

Conditions:

Kidney Cancer

Kidney Neoplasms

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

A proposed new tool ('DIPLANN-tool' - Digital Planning in Nephrectomy) for predicting kidney perfusion zones on a segmented 3D model during robot-assisted partial nephrectomy (RAPN) for localized rena...

Detailed Description

BACKGROUND: For patients diagnosed with localized kidney cancer, two main options exist to surgically remove the kidney tumor. During radical nephrectomy (RN), the entire kidney is removed. During pa...

Eligibility Criteria

Inclusion

  • aged 18 years or above
  • cT1-2 N0 M0 renal mass
  • planned to undergo RAPN
  • multiphase CT scan with arterial phase available
  • voluntary given and written informed consent
  • sufficient in at least one of the study languages: Dutch, English, French
  • For the primary objective, SC needs to be deemed possible either according to the DIPLANN-tool in combination with conventional CT imaging or according to conventional CT imaging only, as assessed by an independent surgeon (between inclusion and randomization) who will not be involved in the RAPN surgical procedure, in order to be included in the analysis set. On the DIPLANN tool, SC is deemed feasible if \>= 90% tumor ischemia and \<= 70% renal parenchyma ischemia can be achieved. If these criteria are met, but it is technically or anatomically not feasible according to the independent surgeon to perform SC, he can deviate from these criteria and thus claim SC is not deemed possible. The results for the total population (patients in which SC is deemed possible AND impossible pre-operatively by an independent surgeon) will also be analyzed as a secondary objective.

Exclusion

  • \> 3 ipsilateral renal masses
  • women who are pregnant or breastfeeding
  • previous renal surgery that is expected to complicate renal cancer surgery
  • cT ≥ 3
  • planned off-clamp resection
  • cognitive disorder which impedes with completing study questionnaires

Key Trial Info

Start Date :

June 27 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2027

Estimated Enrollment :

235 Patients enrolled

Trial Details

Trial ID

NCT06536439

Start Date

June 27 2024

End Date

January 1 2027

Last Update

April 1 2025

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

AZORG

Aalst, Belgium, 9300

2

AZ Sint-Jan

Bruges, Belgium, 8000

3

ZOL

Genk, Belgium, 3600

4

AZ Maria Middelares

Ghent, Belgium, 9000